Walleye Capital LLC Organogenesis Holdings Inc. Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $41,250 - $93,357	-21,711 Reduced 41.89%	30,123 $100,000
Q1 2023 May 15, 2023	BUY	$1.89 - $2.93 $60,001 - $93,018	31,747 Added 158.05%	51,834 $110,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $49,815 - $68,898	20,087 New	20,087 $54,000
Q2 2022 Aug 08, 2022	BUY	$4.74 - $8.15 $72,782 - $125,143	15,355 New	15,355 $75,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $827,120 - $1.29 Million	-55,437 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.33 - $21.06 $391,400 - $1.12 Million	-53,397 Reduced 49.06%	55,437 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $395,067 - $819,520	108,834 New	108,834 $820,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.